Document Type
Article
Language
eng
Format of Original
14 p.
Publication Date
9-2008
Publisher
Lippincott Williams & Wilkins, Inc.
Source Publication
Journal of Cardiovascular Pharmacology
Source ISSN
0160-2446
Original Item ID
doi: 10.1097/FJC.0b013e3181831337
Abstract
Inhibition of Na+/H+ exchange (NHE) during ischemia reduces cardiac injury due to reduced reverse mode Na+/Ca2+ exchange. We hypothesized that activating NHE-1 at buffer pH 8 during ischemia increases mitochondrial oxidation, Ca2+ overload, and reactive O2 species (ROS) levels and worsens functional recovery in isolated hearts and that NHE inhibition reverses these effects. Guinea pig hearts were perfused with buffer at pH 7.4 (control) or pH 8 +/- NHE inhibitor eniporide for 10 minutes before and for 10 minutes after 35- minute ischemia and then for 110 minutes with pH 7.4 buffer alone. Mitochondrial NADH and FAD, [Ca2+], and superoxide were measured by spectrophotofluorometry. NADH and FAD were more oxidized, and cardiac function was worse throughout reperfusion after pH 8 versus pH 7.4, Ca2+ overload was greater at 10-minute reperfusion, and superoxide generation was higher at 30-minute reperfusion. The pH 7.4 and eniporide groups exhibited similar mitochondrial function, and cardiac performance was most improved after pH 7.4+eniporide. Cardiac function on reperfusion after pH 8+eniporide was better than after pH 8. Percent infarction was largest after pH 8 and smallest after pH 7.4+eniporide. Activation of NHE with pH 8 buffer and the subsequent decline in redox state with greater ROS and Ca2+ loading underlie the poor functional recovery after ischemia and reperfusion.
Recommended Citation
Aldakkak, Mohammed; Stowe, David F.; Heisner, James S.; Spence, Marisha; and Camara, Amadou K.S., "Enhanced Na+/H+ Exchange During Ischemia and Reperfusion Impairs Mitochondrial Bioenergetics and Myocardial Function" (2008). Biomedical Engineering Faculty Research and Publications. 320.
https://epublications.marquette.edu/bioengin_fac/320
Comments
Accepted version. Journal of Cardiovascular Pharmacology. Vol. 52, No.3 (September 2008):236-244. DOI. © 2008 Lippincott Williams & Wilkins, Inc. Used with permission.